![Kevin Sarney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kevin Sarney
Direttore Finanziario/CFO presso
ATARA BIOTHERAPEUTICS, INC.
Profilo
Kevin G.
Sarney is Chief Financial Officer at Atara Biotherapeutics, Inc. since 2026.
Formerly, Mr. Sarney was Chief Accounting Officer at NitroMed, Inc., Vice President-Finance & Administration at Avaxia Biologics, Inc. from 2013 to 2014, and Chief Accounting Officer & Vice President-Finance at Enumeral Biomedical Holdings, Inc. from 2014 to 2018.
Education includes an MBA from Boston University, graduate studies at Suffolk University, and undergraduate studies at the University of Hartford.
Posizioni attive di Kevin Sarney
| Società | Posizione | Inizio |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Direttore Finanziario/CFO | 26/06/2026 |
Precedenti posizioni note di Kevin Sarney
| Società | Posizione | Fine |
|---|---|---|
| ENUMERAL BIOMEDICAL HOLDINGS INC | Amministratore Delegato | - |
Avaxia Biologics, Inc.
 Avaxia Biologics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Direttore Finanziario/CFO | 01/07/2014 |
NitroMed, Inc.
 NitroMed, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies pharmaceuticals | Comptroller/Controller/Auditor | 27/01/2009 |
Formazione di Kevin Sarney
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
23
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
NitroMed, Inc.
NitroMed, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies pharmaceuticals | Health Technology |
Avaxia Biologics, Inc.
Avaxia Biologics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Enumeral Biomedical Holdings, Inc.
 Enumeral Biomedical Holdings, Inc. BiotechnologyHealth Technology Develops novel antibody immunotherapies designed to help immune system attack diseased cells | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Suffolk University
 Suffolk University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Hartford
 University of Hartford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
